Similar Bronchodilation with Formoterol Delivered by Aerolizer or Turbuhaler

J Lötvall; A Mellén; P Arvidsson; M Palmqvist; P Radielovic; J Kottakis; P Pfister

doi:10.1155/1999/193245

Canadian Respiratory Journal (Jan 1999)

Similar Bronchodilation with Formoterol Delivered by Aerolizer or Turbuhaler

J Lötvall,
A Mellén,
P Arvidsson,
M Palmqvist,
P Radielovic,
J Kottakis,
P Pfister

Affiliations

J Lötvall: Department of Respiratory Medicine and Allergology, Institute of Heart and Lung Diseases, Göteborg University, Sahlgrenska University Hospital, Gothenburg, Sweden
A Mellén: Department of Respiratory Medicine and Allergology, Institute of Heart and Lung Diseases, Göteborg University, Sahlgrenska University Hospital, Gothenburg, Sweden
P Arvidsson: Department of Respiratory Medicine and Allergology, Institute of Heart and Lung Diseases, Göteborg University, Sahlgrenska University Hospital, Gothenburg, Sweden
M Palmqvist: Department of Respiratory Medicine and Allergology, Institute of Heart and Lung Diseases, Göteborg University, Sahlgrenska University Hospital, Gothenburg, Sweden
P Radielovic: Clinical Development & Regulatory Affairs, Novartis Pharma, Basel, Switzerland
J Kottakis: Medical School, University of Crete, Greece
P Pfister: Clinical Development & Regulatory Affairs, Novartis Pharma, Basel, Switzerland

DOI: https://doi.org/10.1155/1999/193245
Journal volume & issue: Vol. 6, no. 5
pp. 412 – 416

Abstract

Read online

BACKGROUND: In many countries, two dry powder formulations of inhaled formoterol are available for clinical use; one uses a single-dose device (Foradil, Aerolizer), and the other uses a multiple-dose device (Oxis, Turbuhaler).

Published in Canadian Respiratory Journal

ISSN: 1198-2241 (Print); 1916-7245 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
Website: https://onlinelibrary.wiley.com/journal/7503

About the journal